The recent studies have indicated that overexpression of H19 also promoted EMT progression in EC, GC, GBC, and CRC [12–14, 20] in vitro, which suggested that lncRNA H19 might play an important role in invasiveness and metastasis, as a biomarker for prognosis of digestive system cancers. Here, H19 is linked to gastric cancer.